Sex Modulates Cognitive Association of Lewy Body Pathology
Objective: To assess whether the association between Lewy body (LB) pathology stages and cognition differs for women and men Background: Progression of LB pathology is…Illusory responses across the Lewy body disease spectrum
Objective: To study pareidolias in patients across the Lewy body disease-spectrum, including those without psychosis. Background: Pareidolias are specific illusions of faces and objects perceived…Investigating genetic risk factors for Lewy body dementia
Objective: We aim to investigate the genetic mutations related to the development of dementia in Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB)…FDG-PET features of Lewy body dementia among patients with amnestic presentations typical for Alzheimer’s disease
Objective: To better understand the role of FDG-PET for identifying dementia with Lewy bodies (DLB) in the context of Alzheimer’s disease (AD)-like amnestic presentations, we…Safety, Target Engagement and Effects of Bosutinib in Dementia with Lewy Bodies
Objective: To investigate the safety, biomarkers effects and determine the lowest effective dose of Bosutinibin Dementia with Lewy Bodies (DLB) Background: The effects of bosutinib,…Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body disease.
Objective: To investigate the influence of neuropsychiatric symptoms (NPS) on early cognitive decline in patients with Lewy body disease (LBD). Background: NPS in LBD, including…Plasma p-tau181 is increased in Lewy body dementia and relates to cognitive performance
Objective: To compare plasma p-tau181 concentration in Parkinson’s disease (PD), Lewy body dementia (LBD) and healthy controls and to examine the relationship between ptau-181 concentration…Lewy body disease clinical subgroups present similar disease progression rates
Objective: To characterize LBD clinical subgroups and identify possible differences in disease progression. Background: Patients with Lewy body disease (LBD) present a wide variety of…Survival and progression in GBA-associated dementia with Lewy bodies
Objective: To assess the impact of GBA mutations and APOE polymorphisms on progression and survival in a cohort of Ashkenazi Jewish (AJ) patients with DLB.…AMP PD: Collaborating in the discovery of biomarkers to accelerate the development of therapies for Parkinson’s disease
Objective: The Accelerating Medicines Partnership in Parkinson’s Disease (AMP PD; https://amp-pd.org) aims to identify and validate diagnostic, prognostic, and progression biomarkers for Parkinson’s Disease (PD).…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 23
- Next Page »